NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.98
+0.22 (1.72%)
Mar 6, 2026, 11:04 AM EST - Market open
NextCure Employees
NextCure had 43 employees as of December 31, 2024. The number of employees decreased by 39 or -47.56% compared to the previous year.
Employees
43
Change (1Y)
-39
Growth (1Y)
-47.56%
Revenue / Employee
n/a
Profits / Employee
-$1,298,698
Market Cap
45.50M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 70 |
| MiNK Therapeutics | 23 |
| AN2 Therapeutics | 22 |
| Veru Inc. | 20 |
| Lipocine | 16 |
| Apollomics | 13 |
| Telomir Pharmaceuticals | 9 |
| Lite Strategy | 4 |
NXTC News
- 19 hours ago - NextCure Provides Business Update and Reports Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - NextCure Provides Business Update - GlobeNewsWire
- 3 months ago - NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts - GlobeNewsWire
- 4 months ago - NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 4 months ago - NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States - GlobeNewsWire
- 6 months ago - NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire